Table 2.
Ref. | OUD (N, Fn) | HC (N, Fn) | Drug | Status | Acute drug? | Design | Task | Findings |
---|---|---|---|---|---|---|---|---|
Gradin et al. [57] | 30, 0F | 23, 0F | H | MMT | 15 pre, 15 post MMT# | Cross-sectional | Monetary reward/loss | OUD < HC (win vs. no-win): caudate, IPL, precuneus, cuneus, cerebellum |
OUD < HC (loss avoidance vs. loss): insula, IFG, ventral striatum, caudate, PHG, SFG, MiFG, cerebellum | ||||||||
Yip et al. [58] | 24, 16F | 21, 12F | H | MMT | — | Cross-sectional | Monetary reward/loss | OUD < HC (reward vs. loss): PCC, precuneus, IFG, dlPFC, insula |
Wang et al. [63] | 16, 0F | 16, 0F | H | AB | — | Cross-sectional | Affective images | OUD < HC (affective vs. neutral): amygdala |
Schmidt et al. [64] | 22, 8F | 17, 4F | H | HMT | Heroin vs. saline | Random, DB, CO | Fearful faces | OUD > HC (fearful vs. neutral - saline only): L amygdala (ROI analysis) |
Heroin < saline (fearful vs. neutral - OUD only): L amygdala (ROI analysis) | ||||||||
Schmidt et al. [65]a | 22, 8F | 17, 4F | H | HMT | Heroin vs. saline | Reanalysis of [64] | Fearful faces | OUD > HC (fearful vs. neutral – saline only): L fusiform-amygdala connectivity, R amygdala-R OFC connectivity |
Heroin < saline (fearful vs. neutral – OUD only): | ||||||||
L fusiform – L amygdala connectivity, R amygdala-R OFC connectivity | ||||||||
Fu et al. [69] | 20, 0F | 18, 0F | H | AB | — | Cross-sectional | Go/NoGo | OUD < HC (Go/NoGo vs. Go): mPFC, ACC, IFG, MeTG. insula, uncus, PHG, precuneus, SPL, MiTG |
Schmidt et al. [70] | 27, 7F | — | H | HMT | Heroin vs. saline | Random, DB, CO | Go/no-go | Heroin < saline (No-Go vs. Go; No-Go vs. Oddball, and Oddball vs. Go trials): IFG (ROI analysis) |
Yucel et al. [71] | 24, 11F | 24, 11F | H | 10 MMT 14 BMT | — | Cross-sectional | Multi-Source Interference | OUD < HC (con. vs. incon): lateral premotor, superior temporal, PMC |
OUD > HC (con. vs. incon): superior & inferior parietal, occipital, lPFC, cerebellum |
N total sample size, Fn number of female participants, Ref. reference, OUD opioid-use disorder, HC healthy control, F female, H heroin, MMT methadone maintenance treatment, BMT buprenorphine maintenance treatment, AB abstinent, HMT heroin maintenance treatment, random, DB, CO randomized, double-blind, cross-over, IPL inferior parietal lobule, IFG inferior frontal gyrus, PHG parahippocampal gyrus, SFG superior frontal gyrus, MiFG middle frontal gyrus, PCC posterior cingulate cortex, dlPFC dorsolateral prefrontal cortex, L left, ROI region of interest, R right, OFC orbitofrontal cortex, con. congruent, incon. incongruent, PMC primary motor cortex, lPFC lateral prefrontal cortex, ACC anterior cingulate cortex, MeTG medial temporal gyrus, SPL superior parietal lobule, MiTG middle temporal gyrus, ? not reported
aRe-analysis of [64]